These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Practical Use of Pharmacotherapy for Obesity. Igel LI; Kumar RB; Saunders KH; Aronne LJ Gastroenterology; 2017 May; 152(7):1765-1779. PubMed ID: 28192104 [TBL] [Abstract][Full Text] [Related]
46. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation. Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002 [TBL] [Abstract][Full Text] [Related]
47. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review. Koponen H; Saari K; Savolainen M; Isohanni M Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538 [TBL] [Abstract][Full Text] [Related]
48. The implications of weight changes with antipsychotic treatment. Sussman N J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946 [TBL] [Abstract][Full Text] [Related]
49. Antipsychotic-induced weight gain: a comprehensive research synthesis. Allison DB; Mentore JL; Heo M; Chandler LP; Cappelleri JC; Infante MC; Weiden PJ Am J Psychiatry; 1999 Nov; 156(11):1686-96. PubMed ID: 10553730 [TBL] [Abstract][Full Text] [Related]
50. Metabolic consequences of atypical antipsychotic drugs. Lebovitz HE Psychiatr Q; 2003; 74(3):277-90. PubMed ID: 12918602 [TBL] [Abstract][Full Text] [Related]
51. A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics. Nwosu BU; Meltzer B; Maranda L; Ciccarelli C; Reynolds D; Curtis L; King J; Frazier JA; Lee MM J Pediatr Endocrinol Metab; 2011; 24(9-10):619-26. PubMed ID: 22145446 [TBL] [Abstract][Full Text] [Related]
52. Drug-induced hyperphagia: what can we learn from psychiatric medications? Jensen GL JPEN J Parenter Enteral Nutr; 2008; 32(5):578-81. PubMed ID: 18753398 [TBL] [Abstract][Full Text] [Related]
53. Weight gain and metabolic syndrome among young patients on antipsychotic medication: what do we know and where do we go? Eapen V; John G Australas Psychiatry; 2011 Jun; 19(3):232-5. PubMed ID: 21682621 [TBL] [Abstract][Full Text] [Related]
54. Do reductions in ghrelin contribute towards antipsychotic-induced weight gain? Firth J; Teasdale SB; Jackson SE; Vancampfort D; Siskind D; Sarris J; Solmi M Schizophr Res; 2019 Aug; 210():301-302. PubMed ID: 30595440 [No Abstract] [Full Text] [Related]
55. Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects. Kennedy A; Tapp A; Kelly WS; Kilzieh N; Wood AE Essent Psychopharmacol; 2006; 7(1):1-14. PubMed ID: 16989288 [TBL] [Abstract][Full Text] [Related]
56. A review of the effect of atypical antipsychotics on weight. Nasrallah H Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():83-96. PubMed ID: 12504074 [TBL] [Abstract][Full Text] [Related]
57. Metabolic syndrome with the atypical antipsychotics. Pramyothin P; Khaodhiar L Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):460-6. PubMed ID: 20717020 [TBL] [Abstract][Full Text] [Related]
58. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. de Silva VA; Suraweera C; Ratnatunga SS; Dayabandara M; Wanniarachchi N; Hanwella R BMC Psychiatry; 2016 Oct; 16(1):341. PubMed ID: 27716110 [TBL] [Abstract][Full Text] [Related]
59. Psychosis and delirium following metabolife use. Verduin ML; Labbate LA Psychopharmacol Bull; 2002; 36(3):42-5. PubMed ID: 12473963 [TBL] [Abstract][Full Text] [Related]